587 related articles for article (PubMed ID: 28821472)
1. Surgical Findings and Outcomes in Premenopausal Breast Cancer Patients Undergoing Oophorectomy: A Multicenter Review From the Society of Gynecologic Surgeons Fellows Pelvic Research Network.
Harvey LFB; Abramson VG; Alvarez J; DeStephano C; Hur HC; Lee K; Mattingly P; Park B; Piszczek C; Seifi F; Stuparich M; Yunker A
J Minim Invasive Gynecol; 2018 Jan; 25(1):111-115. PubMed ID: 28821472
[TBL] [Abstract][Full Text] [Related]
2. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
Miller H; Pipkin LS; Tung C; Hall TR; Masand RP; Anderson ML
J Minim Invasive Gynecol; 2017; 24(5):772-776. PubMed ID: 28285055
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy.
Poon C; Hyde S; Grant P; Newman M; Ireland Jenkin K
Int J Gynecol Cancer; 2016 Oct; 26(8):1415-20. PubMed ID: 27488216
[TBL] [Abstract][Full Text] [Related]
4. Risk-reducing Bilateral Salpingo-oophorectomy: Assessing the Incidence of Occult Ovarian Cancer and Surgeon Adherence to Recommended Practices.
Newcomb LK; Toal CT; Rindos NB; Wang L; Mansuria SM
J Minim Invasive Gynecol; 2020; 27(7):1511-1515. PubMed ID: 31927044
[TBL] [Abstract][Full Text] [Related]
5. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Bogani G; Tagliabue E; Signorelli M; Chiappa V; Carcangiu ML; Paolini B; Casarin J; Scaffa C; Gennaro M; Martinelli F; Borghi C; Ditto A; Lorusso D; Raspagliesi F
J Minim Invasive Gynecol; 2017; 24(5):837-842. PubMed ID: 28479170
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).
Saccardi C; Zovato S; Spagnol G; Bonaldo G; Marchetti M; Alessandrini L; Tognazzo S; Guerriero A; Vitagliano A; Laganà AS; Noventa M
Gynecol Oncol; 2021 Nov; 163(2):364-370. PubMed ID: 34465478
[TBL] [Abstract][Full Text] [Related]
8. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
[TBL] [Abstract][Full Text] [Related]
9. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
Gornjec A; Merlo S; Novakovic S; Stegel V; Gazic B; Perhavec A; Blatnik A; Krajc M
Radiol Oncol; 2020 May; 54(2):180-186. PubMed ID: 32463390
[TBL] [Abstract][Full Text] [Related]
11. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
12. Adherence to risk-reducing salpingo-oophorectomy guidelines among gynecologic oncologists compared to general gynecologists.
Blustein P; Werner SR; Uppalapati P; Leung TM; Husk GA; Pereira EB; Whyte JS; Villella JA
Am J Obstet Gynecol; 2023 Sep; 229(3):280.e1-280.e8. PubMed ID: 37308046
[TBL] [Abstract][Full Text] [Related]
13. Incidence of intraepithelial fallopian tube neoplasias in mexican women over 40 years of age that underwent elective hysterectomy.
Briseño Campos AG; Cruz Rodríguez A; García Perales MO; Serna Vela FJ; Camarillo Elizalde DG; Robles Martínez MDC
J Ovarian Res; 2019 Jun; 12(1):54. PubMed ID: 31182132
[TBL] [Abstract][Full Text] [Related]
14. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
[TBL] [Abstract][Full Text] [Related]
15. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
16. Health Care Provider Adherence to Surgical Guidelines for Risk-Reducing Salpingo-Oophorectomy.
Wilhite AM; Oestreich MC; Olson M; Bedell SM; Westenberg D; Bangdiwala A; Ikramuddin S; Sanchez-Avila M; Madoff RD; Khalifa MA; Erickson BK
Obstet Gynecol; 2019 Sep; 134(3):520-526. PubMed ID: 31403600
[TBL] [Abstract][Full Text] [Related]
17. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
Ayres C; Ratnayake G; McNally O; Quinn M
Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
[TBL] [Abstract][Full Text] [Related]
18. Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
Samimi G; Trabert B; Duggan MA; Robinson JL; Coa KI; Waibel E; Garcia E; Minasian LM; Sherman ME
Gynecol Oncol; 2018 Mar; 148(3):515-520. PubMed ID: 29395311
[TBL] [Abstract][Full Text] [Related]
19. Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?
Laokulrath N; Warnnissorn M; Chuangsuwanich T; Hanamornroongruang S
J Obstet Gynaecol Res; 2019 Mar; 45(3):665-670. PubMed ID: 30506766
[TBL] [Abstract][Full Text] [Related]
20. Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Rush SK; Swisher EM; Garcia RL; Pennington KP; Agnew KJ; Kilgore MR; Norquist BM
Gynecol Oncol; 2020 May; 157(2):514-520. PubMed ID: 32199636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
